The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.
We have studied the effects of the extracellular molecular chaperone, clusterin, on the in vitro aggregation of mutational variants of human lysozyme, including one associated with familial amyloid disease. The aggregation of the amyloidogenic variant I56T is inhibited significantly at clusterin to...
主要な著者: | Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
著者:: Johnson, R, 等
出版事項: (2005) -
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
著者:: Patricia Yuste-Checa, 等
出版事項: (2021-08-01) -
The significance of the location of mutations for the native-state dynamics of human lysozyme
著者:: Ahn, M, 等
出版事項: (2016) -
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
著者:: Abigail K. Elias, 等
出版事項: (2022-10-01) -
Expression and purification of chaperone-active recombinant clusterin.
著者:: Rebecca A Dabbs, 等
出版事項: (2014-01-01)